6-[3-[(5-bromo-1H-indol-3-yl)methylideneamino]-2-pyridin-3-ylimino-1,3-thiazol-4-yl]-4H-1,4-benzoxazin-3-one

C25H17BrN6O2S — CID 135839023

IUPAC6-[3-[(5-bromo-1H-indol-3-yl)methylideneamino]-2-pyridin-3-ylimino-1,3-thiazol-4-yl]-4H-1,4-benzoxazin-3-one
SMILESO=C1COc2ccc(-c3cs/c(=N\c4cccnc4)n3N=Cc3c[nH]c4ccc(Br)cc34)cc2N1
InChIInChI=1S/C25H17BrN6O2S/c26-17-4-5-20-19(9-17)16(10-28-20)11-29-32-22(14-35-25(32)30-18-2-1-7-27-12-18)15-3-6-23-21(8-15)31-24(33)13-34-23/h1-12,14,28H,13H2,(H,31,33)/b29-11?,30-25-
InChIKeyVLNJORAHFIZRMH-MIHCIGPXSA-N
MW545.42 g/mol
LogP5.30
Rot. Bonds4

About 6-[3-[(5-bromo-1H-indol-3-yl)methylideneamino]-2-pyridin-3-ylimino-1,3-thiazol-4-yl]-4H-1,4-benzoxazin-3-one

6-[3-[(5-bromo-1H-indol-3-yl)methylideneamino]-2-pyridin-3-ylimino-1,3-thiazol-4-yl]-4H-1,4-benzoxazin-3-one (PubChem CID 135839023) has the molecular formula C25H17BrN6O2S and a molecular weight of 545.42 g/mol. Its IUPAC name is 6-[3-[(5-bromo-1H-indol-3-yl)methylideneamino]-2-pyridin-3-ylimino-1,3-thiazol-4-yl]-4H-1,4-benzoxazin-3-one.

Molecular Properties

Compound Name6-[3-[(5-bromo-1H-indol-3-yl)methylideneamino]-2-pyridin-3-ylimino-1,3-thiazol-4-yl]-4H-1,4-benzoxazin-3-one
PubChem CID135839023
Molecular FormulaC25H17BrN6O2S
Molecular Weight545.42 g/mol
Exact Mass544.03
IUPAC Name6-[3-[(5-bromo-1H-indol-3-yl)methylideneamino]-2-pyridin-3-ylimino-1,3-thiazol-4-yl]-4H-1,4-benzoxazin-3-one
SMILESO=C1COc2ccc(-c3cs/c(=N\c4cccnc4)n3N=Cc3c[nH]c4ccc(Br)cc34)cc2N1
InChIInChI=1S/C25H17BrN6O2S/c26-17-4-5-20-19(9-17)16(10-28-20)11-29-32-22(14-35-25(32)30-18-2-1-7-27-12-18)15-3-6-23-21(8-15)31-24(33)13-34-23/h1-12,14,28H,13H2,(H,31,33)/b29-11?,30-25-
InChIKeyVLNJORAHFIZRMH-MIHCIGPXSA-N
XLogP5.30
TPSA96.66 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds4
Heavy Atoms35
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500545.42
LogP ≤ 55.30
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze 6-[3-[(5-bromo-1H-indol-3-yl)methylideneamino]-2-pyridin-3-ylimino-1,3-thiazol-4-yl]-4H-1,4-benzoxazin-3-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 6-[3-[(5-bromo-1H-indol-3-yl)methylideneamino]-2-pyridin-3-ylimino-1,3-thiazol-4-yl]-4H-1,4-benzoxazin-3-one?
The IUPAC name of 6-[3-[(5-bromo-1H-indol-3-yl)methylideneamino]-2-pyridin-3-ylimino-1,3-thiazol-4-yl]-4H-1,4-benzoxazin-3-one (CID 135839023) is 6-[3-[(5-bromo-1H-indol-3-yl)methylideneamino]-2-pyridin-3-ylimino-1,3-thiazol-4-yl]-4H-1,4-benzoxazin-3-one.
What is the SMILES notation for 6-[3-[(5-bromo-1H-indol-3-yl)methylideneamino]-2-pyridin-3-ylimino-1,3-thiazol-4-yl]-4H-1,4-benzoxazin-3-one?
The canonical SMILES for 6-[3-[(5-bromo-1H-indol-3-yl)methylideneamino]-2-pyridin-3-ylimino-1,3-thiazol-4-yl]-4H-1,4-benzoxazin-3-one is O=C1COc2ccc(-c3cs/c(=N\c4cccnc4)n3N=Cc3c[nH]c4ccc(Br)cc34)cc2N1.
What is the InChIKey of 6-[3-[(5-bromo-1H-indol-3-yl)methylideneamino]-2-pyridin-3-ylimino-1,3-thiazol-4-yl]-4H-1,4-benzoxazin-3-one?
The InChIKey is VLNJORAHFIZRMH-MIHCIGPXSA-N. The full InChI is InChI=1S/C25H17BrN6O2S/c26-17-4-5-20-19(9-17)16(10-28-20)11-29-32-22(14-35-25(32)30-18-2-1-7-27-12-18)15-3-6-23-21(8-15)31-24(33)13-34-23/h1-12,14,28H,13H2,(H,31,33)/b29-11?,30-25-.
What are the key properties of 6-[3-[(5-bromo-1H-indol-3-yl)methylideneamino]-2-pyridin-3-ylimino-1,3-thiazol-4-yl]-4H-1,4-benzoxazin-3-one?
6-[3-[(5-bromo-1H-indol-3-yl)methylideneamino]-2-pyridin-3-ylimino-1,3-thiazol-4-yl]-4H-1,4-benzoxazin-3-one has a molecular weight of 545.42 g/mol, XLogP of 5.30, 4 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[3-[(5-bromo-1H-indol-3-yl)methylideneamino]-2-pyridin-3-ylimino-1,3-thiazol-4-yl]-4H-1,4-benzoxazin-3-one is sourced from PubChem (CID 135839023), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).